Cargando…
Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
Angiopoietin-like 3 (ANGPTL3) is a regulator of plasma triglyceride (TRG) levels due to its inhibitory action on the activity of lipoprotein lipase (LPL). ANGPTL3 is proteolytically cleaved by proprotein convertases to generate an active N-terminal domain, which forms a complex with ANGPTL8 orchestr...
Autores principales: | Christopoulou, Eliza, Elisaf, Moses, Filippatos, Theodosios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421734/ https://www.ncbi.nlm.nih.gov/pubmed/30944669 http://dx.doi.org/10.1155/2019/6578327 |
Ejemplares similares
-
Non-hemorrhage-related adverse effects of rivaroxaban
por: Christopoulou, Eliza C., et al.
Publicado: (2017) -
Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes
por: Papakitsou, Ioanna, et al.
Publicado: (2019) -
Thiazide–associated hyponatremia in the elderly: what the clinician needs to know
por: Liamis, George, et al.
Publicado: (2016) -
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017) -
Hyponatremia in the elderly: challenges and solutions
por: Filippatos, Theodosios D, et al.
Publicado: (2017)